Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...
Glenn Hussey went to The Ottawa Hospital for a regular checkup to monitor his smouldering multiple myeloma — a precursor to ...
Hosted on MSN22h
Causes and Risk Factors of Multiple MyelomaMedically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a white ...
Flow Space on MSN14h
A Story of Strength and Hope: How Allison Freedman Overcame Multiple Myeloma and Climbed KilimanjaroAt just 42 years old, Allison Freedman's life took an unexpected and devastating turn. She was a busy mom raising ...
A SINGLE mum’s suspected diabetes symptoms turned out to be incurable cancer. Jodie Hill, 46, was told she had three months ...
Don Wright of Stillwater, a retired engineer, lawyer, and father of three, ran his first marathon in 2003, at the age of 61.
The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 ...
Legend Biotech Corporation (NASDAQ:LEGN) is a clinical-stage company that develops, discovers, manufactures, and ...
Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth plans
As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...
Panelists discuss how the CEPHEUS trial demonstrates the comparative efficacy and safety of subcutaneous daratumumab combined with VRd vs VRd alone in patients with transplant-ineligible or transplant ...
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) shares are going to reverse split on Thursday, January 30th. The 1-40 reverse split was announced on Friday, January 17th. The number of shares owned by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback